Meanwhile, GLP-1s are not yet a topic in Italy, according to Giulia Scalbi, associate principal at Mintel
The difference is mostly in speed and tolerance, not in whether they work
Whatever the reason you came off a GLP-1 medication, you're far from alone: Within two years, nearly three in four people taking these medications for weight loss stop, according to a 2025 study of 125,000 patients
Effect of dietary lipid, carnitine and exercise on lipid profile in rat blood, liver and muscle
hypoglycemia risk if on insulin) eGFR below 30 (tirzepatide exclusion in SURMOUNT-5) Recent cardiac event or NYHA Class IV heart failure Active suicidal ideation (trials excluded PHQ-9 scores of 15 or above) If your tirzepatide vs semaglutide question is pure weight loss without comorbidities, tirzepatide wins on the numbers
Apr, 2026